7.13
Modèle ouvert à deux compartiments : administration de bolus IV
Le modèle à deux compartiments pour l'administration de bolus intraveineux (IV) illustre la distribution du médicament dans le corps, en le subdivisan…
Le modèle à deux compartiments pour l’administration d’un bolus intraveineux comprend des compartiments centraux et périphériques, représentant la distribution d’un médicament dans le corps.
Letaux de distribution de premier ordre ou les constantes de transfert comme k12 et k21 désignent le taux de transfert réversible de médicament entre les compartiments.
Les constantes hybrides de premier ordre pour la distribution rapide et l’élimination lente dépendent de k12, k21 et de la constante de vitesse d’élimination du compartiment central k10 .
Le profil concentration-temps plasmatique après l’administration d’un bolus IV suit une courbe biexponentielle, indiquant les phases de distribution et d’élimination.
La méthode des résidus peut résoudre la courbe de distribution biexponentielle en exposants individuels. La pente de la ligne résiduelle obtenue à partir du graphique semi-logarithmique des valeurs de concentration plasmatique de médicament en fonction du temps donne les constantes de transfert.
La demi-vie d’élimination est calculable à partir de la constante de vitesse d’élimination pour l’ensemble du corps β.
D’autres paramètres pharmacocinétiques, tels que le volume de distribution et la clairance, peuvent être déterminés.
View the full transcript and gain access to JoVE Core videos
Q1: What are the central and peripheral compartments in the two-compartment model?
The two-compartment model divides the body into central and peripheral compartments to represent drug distribution. The central compartment includes the blood and highly perfused tissues where the drug is administered intravenously. The peripheral compartment represents less perfused tissues. Drug reversibly transfers between these compartments at rates determined by transfer constants k12 and k21, allowing the model to capture the biphasic nature of drug disposition.
Q2: Why does plasma concentration show a bi-exponential decline after IV bolus administration?
Plasma concentration exhibits a bi-exponential decline because two distinct disposition processes occur sequentially: distribution and elimination. Initially, the drug rapidly distributes from the central compartment to peripheral tissues, causing a steep concentration drop. Subsequently, the elimination phase dominates as the drug is cleared from the central compartment. This biphasic profile reflects the combined effects of inter-compartmental transfer and elimination rate constants.
Q3: How does the method of residuals help determine transfer constants?
The method of residuals resolves the biexponential distribution curve into individual exponents by plotting plasma drug concentration versus time on a semilog scale. The slope of the residual line obtained from this plot yields the transfer constants k12 and k21, which describe the reversible drug transfer rate between compartments. This graphical technique separates the rapid distribution phase from the slower elimination phase for accurate parameter estimation.
Q4: What pharmacokinetic parameters can be calculated from the elimination rate constant?
From the elimination rate constant β for the entire body, the elimination half-life can be directly calculated. Additionally, other essential pharmacokinetic parameters such as volume of distribution and clearance can be determined using suitable equations. These parameters collectively describe how the drug behaves within the body, including its distribution extent and the rate at which it is removed from circulation.
Q5: What do the transfer constants k12 and k21 represent in the two-compartment model?
The transfer constants k12 and k21 are first-order rate constants that denote the reversible drug transfer rate between central and peripheral compartments. k12 represents the rate of drug movement from the central to peripheral compartment, while k21 represents movement in the opposite direction. These constants, along with the elimination rate constant k10, determine the hybrid first-order constants that govern the rapid distribution and slow elimination phases.
Q6: How do distribution and elimination phases differ in the two-compartment model?
The distribution phase occurs immediately after IV bolus administration when drug rapidly transfers from the central compartment to peripheral tissues, causing a steep plasma concentration decline. The elimination phase follows, characterized by slower concentration decrease as the drug is cleared from the central compartment. The transition between these phases reflects the changing dominance of inter-compartmental transfer versus elimination processes.
Q7: Why is the two-compartment model more realistic than simpler pharmacokinetic approaches?
The two-compartment model more accurately represents drug behavior by accounting for both distribution to peripheral tissues and elimination from the body. Unlike simpler models, it captures the biphasic plasma concentration profile observed clinically, reflecting the physiological reality that drugs distribute unevenly across body tissues. This complexity allows for better prediction of drug concentrations at different times and more accurate dosing recommendations.